INTERNATIONAL PATENT: TAIHO PHARMACEUTICAL CO., LTD., 大鵬薬品工業株式会社 FILES APPLICATION FOR "BRAIN-MIGRATING TUMOR TREATMENT AGENT CONTAINING, AS ACTIVE INGREDIENT, N-(4-(4-AMINO-6-ETHYNYL-5-(QUINOLIN-3-YL)-7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL) BICYCLO[2.2.1]HEPTAN-1-YL)-5-METHYLPYRAZINE-2-CARBOXAMIDE OR SALT THEREOF"

GENEVA, June 24 -- TAIHO PHARMACEUTICAL CO., LTD. (1-27, Kandanishiki-cho, Chiyoda-ku, Tokyo1018444), 大鵬薬品工業株式会社 (東京都千代田区神田錦町１－２７) filed a patent application (PCT/JP2024/044041) for "BRAIN-MIGRATING TUMOR TREATMENT AGENT CONTAINING, AS ACTIVE INGREDIENT, N-(4-(4-AMINO-6-ETHYNYL-5-(QUINOLIN-3-YL)-7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL) BICYCLO[2.2.1]HEPTAN-1-YL)-5-METHYLPYRAZINE-2-CARBOXAMIDE OR SALT THEREOF" on Dec 12, 2024. With publication no. WO/2025/127108, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was su...